#esmo21 highlights on pembro chemo in 1st-line metastatic cervical cancer: the keynote-826 study
Published 2 years ago • 2.3K plays • Length 2:26Download video MP4
Download video MP3
Similar videos
-
2:26
keynote-826: pembrolizumab plus chemotherapy for patients with metastatic cervical cancer
-
1:16
keynote 826: pembrolizumab chemo in patients with advanced cervical cancer
-
3:15
highlights on pembro crt in high-risk locally advanced cervical cancer: the keynote-a18 study
-
2:59
#esmo21 highlights on atezolizumab combined with folfoxiri bev in 1st-line mcrc: atezotribe study
-
7:18
keynote-826: pembrolizumab chemotherapy vs placebo chemotherapy for cervical cancer
-
5:13
immunotherapy prolongs survival in recurrent, persistent or metastatic cervical cancer
-
2:19
#esmo21 highlights on pembrolizumab in fully resected high-risk stage ii melanoma: keynote-716 study
-
3:18
gynecologic oncology at esmo congress 2021: trial study in cervical cancer
-
2:51
#esmo21 highlights on adagrasib in patients with krasg12c-mutated crc: the krystal-1 study
-
1:18
incorporating immunotherapy in cervical cancer and endometrial cancer treatment: 2022 esmo florida
-
2:42
#esmo21 highlights on aspirin use in recurrent platinum-resistent ovarian cancer: eortc-1508 study
-
1:35
#esmo21 highlights on a phase i of dual raf/mek inhibitor fak inhibitor in ovarian cancer (frame)
-
2:18
#esmo21 highlights on maintenance olaparib in ovarian cancer previously treated with parpi
-
2:30
#esmo21 highlights on gemcitabine vs mfolfirinox in resected pancreatic cancer: prodige 24/cctg pa6
-
6:38
pembrolizumab with chemotherapy as first line for metastatic cervical cancer
-
2:34
esmo 2021 breast cancer highlights: tulip and keynote-355
-
2:57
esmo 2020 highlights on lenvatinib plus pembrolizumab in advanced solid tumours: leap-005
-
1:04
highlights in breast cancer from esmo 2021